Stock Updates

How has Sanofi:(NYSE:SNY) performed recently?

Sanofi (NYSE: SNY) is a large market cap stock with a market cap of 108781.23. It is in the Drug Manufacturers – Major industry and sector Healthcare, with a current P/E of 22.88, a forward P/E of 13.46 and EPS of 1.86. At a stock price of 42.64 (0.09%) it has a dividend yield of 3.90%.

EPS growth for the last five years have been -4.40%, more recently this last year it has grown by 4.10%. The next year growth is going to be about 0.16% and more long-term 7.10% after five years. EPS growth quarter over quarter is 4.60%. Sales growth for the past five years have been 0.50% and sales growth quarter over quarter is -3.60%.

For performance, Sanofi the past week has seen a gain of 1.67%. For the last month performance for Sanofi is 5.06%. While the last quarter is 3.60% and half year, 8.56%. Finally for the year, performance is -15.67%.

The 52-week high for Sanofi, is at -19.18%, and for the 52-week low it comes to a value of 18.08%. The 20-day simple moving average is 4.63% and 4.25% for the 200-day simple moving average.

Volatility for the week is at 1.08%, and for the month it is 1.32%. Sanofi, has a target price of 52.

In terms of debt, long term debt/equity is *TBA, and for total debt/equity Sanofi has *TBA. The gross margin is 68.80%, while operating margin is *TBA, the profit margin is *TBA. The current ratio is *TBA and the quick ratio is *TBA.

Insider ownership is at 16.40%, with instituitional ownership at 9.70%. Sanofi has a payout ratio of *TBA. With the total shares outstanding coming to 2553.55. The shares float is 2304.36, with the float short at 0.20%, with short ratio coming to 1.97.

In terms of returns, the return on assets see Sanofi, get *TBA, with its returns on investment at 6.50%. Return on equity is *TBA. So will the investors see the target price of 52, reached soon?

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.


About the author

Peter Clarke

Leave a Comment